How to Use Iontophoresis Electrodes: Step-by-Step

Wired iontophoresis uses a reusable dose controller with two disposable components: an active drug-delivery electrode and a return electrode. The active electrode holds the prescribed medication or solution over the treatment site. The return electrode completes the electrical circuit.

Correct setup requires more than attaching two pads. The clinician must verify the medication, formulation, polarity, fill volume, electrical dose, maximum current, electrode placement, and patient-specific precautions before treatment begins.

Important: This article provides a general professional workflow. It does not replace the prescription, medication labeling, controller manual or Instructions for Use packaged with the selected electrode. Product requirements vary.

Clinics can compare compatible supplies in our iontophoresis patches, electrodes, and dose-controller collection.

Iontophoresis Electrode Setup at a Glance

Before Treatment: Verify the Complete Order

Do not begin by choosing a pad or turning on the controller. Begin by confirming exactly what has been prescribed.

Do not determine polarity based on the medication’s abbreviated name or from memory alone. Consult the prescription, pharmacy information, and current product instructions. Our Iontophoresis Medications and Substances Guide provides a literature-based starting point, but it does not replace medication-specific verification.

Screen for Contraindications and Precautions

Known adverse reactions to electrical current, cardiac pacemakers, or other electrically sensitive implants, as well as sensitivity to the administered medication, are contraindications. They also prohibit placement over damaged skin or recent scar tissue, across the chest, across the brain, or in the orbital region.

Before every treatment, assess for:

• A pacemaker, implanted defibrillator or other electrically sensitive device
• Known allergy or sensitivity to the prescribed medication
• Previous adverse response to direct electrical current
• Broken, infected, inflamed or significantly irritated skin
• Recent or incompletely healed scar tissue
• Reduced sensation at either electrode site
• Jewelry or exposed metal near the treatment area
• Topical creams, oils or pain-relief gels on the skin
• An anatomical location prohibited by the electrode or controller instructions

Choose the Correct Iontophoresis Electrode

Electrode selection should be based on the prescribed medication volume, treatment-site anatomy, active-pad shape, and compatibility with the dose controller—not simply on which box is already open.

Wired Iontophoresis Electrode Comparison

Ionto4 Size and Fill-Volume Guide

The Ionto4 IFU lists a maximum application current of 4.0 mA and a maximum dose of 80 mA-min for all four sizes. Those limits apply specifically to Ionto4 and should not be automatically assigned to another electrode family.

What Comes in a Wired Electrode Kit?

Contents differ by product.

A current Ionto4 treatment kit includes the following:

• One active drug-delivery electrode
• One buffered return electrode
• Two alcohol prep swabs

The electrodes are nonsterile, disposable, and not made with natural rubber latex. They are intended for one treatment and must be discarded after use.

Other products may include one alcohol wipe rather than two, may use different return electrode technology, or may provide a different reservoir design. Please inspect the sealed pouch before preparing the patient.

Medication, syringes, and the reusable dose controller are normally supplied separately.

Step 1: Inspect the Electrode Pouch

Before opening the package, confirm:

• The product name and size match the treatment plan.
• The expiration date has not passed.
• The sealed pouch is intact.
• The electrode has not been exposed to excessive heat or moisture.
• The fill volume matches the medication order.
• The connector is compatible with the controller leads.
• No part appears bent, punctured, dried out, or otherwise damaged.

Do not use an electrode that has been altered or damaged. Ionto4 instructions list an optimal storage range of 41°F to 80.6°F, or 5°C to 27°C.

Step 2: Inspect the Treatment and Return Sites

Both electrodes require suitable skin contact.

Choose skin that is:

• Intact
• Clean
• Dry
• Free of lotion and topical gel
• Capable of supporting the full adhesive border
• Free from cuts, razor nicks, active rash and open wounds

Avoid placing an electrode directly over:

• A prominent bone with little soft tissue
• Damaged or recently healed skin
• Inflamed follicles
• A mole when an alternative placement is available
• An area that will be compressed during treatment
• A location prohibited by the product instructions

Instructions advise clinicians to clip hair when necessary rather than shaving immediately before treatment. Shaving can create small skin defects that lower resistance and concentrate current.

Step 3: Prepare the Skin

For wired electrode kits, use the included alcohol prep pad to clean each electrode site thoroughly and then allow the skin to dry completely. Current instructions provide two alcohol pads so the active and return sites can each be prepared.

Do not assume that the same skin-preparation method applies to every iontophoresis product. Certain wearable patches use different preparation instructions. Follow the IFU packaged with the exact product being applied.

Why drying matters

Residual alcohol or excess surface moisture can

• Interfere with adhesion
• Affect current distribution
• Allow an electrode edge to lift
• Increase irritation
• Trigger a high-resistance or circuit warning

Step 4: Fill the Active Drug Electrode

Prepare the active electrode before placing it on the patient.

The electrode should remain attached to its protective liner during filling. Hold it level, load the solution through the fill opening with an appropriately marked syringe, and saturate the full reservoir without soaking the adhesive border.

Recommended filling sequence

1. Confirm the medication, concentration, and volume a second time.
2. Use an appropriately marked syringe.
3. Keep the electrode on its protective liner.
4. Keep the reservoir level.
5. Insert the syringe tip into the designated fill opening.
6. Load the solution at a moderate rate.
7. Watch the entire matrix as it hydrates.
8. Eliminate visible dry areas or air pockets.
9. Prevent medication from reaching the adhesive border.
10. Do not oversaturate the reservoir.

Why fill volume matters

Do not assume that adding more medication improves delivery. The reservoir should be filled according to its instructions and the prescribed medication volume.

Step 5: Apply the Drug-Delivery Electrode

After the reservoir is evenly hydrated:

1. Remove the electrode from its liner.
2. Position the drug matrix over the prescribed treatment target.
3. Lower the electrode onto the skin without folding or stretching it.
4. Press around the adhesive border until a complete seal is formed.
5. Do not press directly on the filled reservoir.
6. Check for leaks, wrinkles, or lifted edges.

Pressing directly over a filled Ionto4 reservoir can force solution out of the matrix and beneath the adhesive.

Do not tape, bind, or tightly compress an iontophoresis electrode unless the product instructions specifically permit it. External pressure can distort the reservoir, create uneven contact, and concentrate current.

Step 6: Position the Return Electrode

The return electrode completes the circuit and should not be treated as an unimportant “ground” pad.

The manufacturer instructs users to place the return electrode

• Over a major muscle
• On the same side of the body
• At least four inches from the active electrode
• Away from bony areas with minimal tissue thickness

Return-Electrode Placement Checklist

Step 7: Connect the Correct Polarity

Turn the iontophoresis controller off or make sure its output is at zero before attaching the leads.

The lead connected to the active drug electrode must match the polarity of the prescribed ion.

Easy way to remember the connection

The drug electrode receives the same polarity as the ion being delivered:

• Negative drug ion → negative active electrode
• Positive drug ion → positive active electrode

This memory aid does not determine whether a medication is actually positive or negative. The clinician must verify the exact formulation.

Step 8: Select Dose and Current

A professional controller such as the ActivaDose II Iontophoresis Dose Controller allows the clinician to select the prescribed electrical dose and set the current. The controller then calculates the treatment time. It can deliver up to 80 mA-min and 4.0 mA, but the electrode’s lower limit takes precedence whenever its instructions permit less.

What mA-min means

Electrical dose = current × time

The table illustrates only dose mathematics. It is not a treatment recommendation.

Follow the lowest applicable limit

The selected treatment must remain within the following limits:

1. The prescribed dose
2. The prescribed current
3. The dose-controller maximum
4. The electrode maximum
5. The medication-specific requirements
6. The patient’s tolerated current

For example, a controller capable of 80 mA-min does not authorize an 80 mA-min treatment when the chosen electrode, medication order, or clinical protocol has a lower limit.

When a lower current may be preferable

A lower current may be appropriate for:

• Small anatomical areas
• Thin or fragile skin
• Patients sensitive to direct current
• Areas with limited soft tissue
• Hands, fingers, feet or other sensitive locations
• Treatment sites that become uncomfortable at a higher setting

Reducing the current increases treatment time when the total mA-min dose remains unchanged. The ActivaDose II automatically recalculates the remaining time when the current is reduced or treatment is paused.

Step 9: Start and Monitor Treatment

Increase current gradually according to the controller instructions. Do not simply set the desired current and walk away.

Monitor:

• Patient sensation
• Skin around both electrode borders
• Complete electrode contact
• Medication leakage
• Lead-wire security
• Controller alarms
• Actual current
• Remaining treatment time
• Signs of an allergic or skin reaction

Expected and Unexpected Sensations

Instructions state that temporary uniform redness may occur beneath either electrode and commonly resolves within several hours. They also warn that burns can result from excessive current density or skin defects.

Pain or burning should never be treated as something the patient must tolerate to complete the programmed dose.

Iontophoresis Troubleshooting Guide

Electrode Reject or Interrupted Circuit

The ActivaDose II can stop current when it detects an unsuitable or interrupted treatment circuit.

Do not repeatedly restart a rejecting controller without identifying the cause.

Resistance-Limit Warning

A controller may be unable to reach the selected current when resistance is too high. Possible contributors include:

• Inadequate skin preparation
• Dry electrode matrix
• Incomplete pad contact
• A lifted adhesive edge
• Poor lead connection
• Unsuitable electrode placement
• A damaged or expired electrode

The ActivaDose II can continue at the highest current it can safely achieve and extend the treatment time accordingly.

Medication Leakage

If medication leaks from the active reservoir:

1. Do not begin or continue current if the surrounding skin is wet.
2. Turn the controller output to zero.
3. Inspect the adhesive and reservoir.
4. Dry the surrounding area.
5. Replace the electrode when the adhesive or fill integrity has been compromised.

Common causes include overfilling, filling while the electrode is tilted, pressing the reservoir after application, or allowing the solution to enter the adhesive border.

Burning Beneath One Small Area

A highly localized burning sensation can indicate concentrated current rather than an evenly distributed treatment.

Potential causes include the following:

• A dry spot in the drug matrix
• A wrinkle beneath the electrode
• A skin defect
• A mole or hair follicle beneath the conductive area
• Metal touching the pad
• Partial pad lift
• Compression over one portion of the electrode
• Current that is too high for the site

Pause immediately and inspect both the skin and electrode. Do not merely lower the current and continue through unexplained burning.

Treatment Time Suddenly Increased

With ActivaDose II, the remaining time increases when:

• The clinician lowers current.
• The device cannot reach the selected current because of resistance.
• Treatment has been paused.
• The controller resumes and recalculates the remaining dose.

That behavior may be normal, but the clinician should still evaluate unexpected resistance warnings.

Step 10: End Treatment Safely

At the end of treatment:

1. Allow the controller to ramp current down to zero.
2. Confirm that no current is flowing.
3. Turn the device off when directed.
4. Disconnect the lead clips.
5. Remove the electrodes slowly from the skin.
6. Inspect the active and return sites.
7. Record any redness, irritation, or blistering.
8. Discard both electrodes.
9. Clean and store the reusable controller and leads according to their instructions.

Never remove iontophoresis electrodes while current is still flowing. Ionto4 instructions specifically require termination of the current source before electrode removal.

Are Wired Iontophoresis Electrodes Reusable?

No. The drug-delivery electrode and return electrode are single-use components.

They should not be:

• Refilled for a second treatment
• Used on another patient
• Stored after medication has been added
• Reapplied after removal
• Cleaned and returned to the pouch
• Used as ordinary TENS or NMES electrodes

Instructions require both electrodes to be discarded after one application.

The dose controller and approved lead wires are reusable when cleaned, maintained, and inspected according to the device manual.

Wired Electrodes vs. Wearable Iontophoresis Patches

This article applies primarily to controller-based drug electrodes.

Clinics wanting direct control over current and treatment time may prefer ActivaDose II with compatible disposable electrodes. Clinics wanting a self-contained treatment may instead compare the wireless products in our iontophoresis collection.

Treatment Documentation Checklist

Record enough information to reproduce and evaluate the treatment.

For coding and treatment-record considerations, review our Iontophoresis Reimbursement Codes and Documentation Guide.

Common Iontophoresis Electrode Mistakes

Frequently Asked Questions

Can standard TENS electrodes be used for iontophoresis?

No. Standard TENS and NMES pads are designed to conduct stimulation current, not hold and deliver medication. Use a dedicated iontophoresis drug electrode and compatible return electrode.

How much medication should be placed in the active electrode?

Use the fill volume specified for the exact electrode size and the prescribed solution. Ionto4 volumes range from 1.5 cc to 4.0 cc, depending on the model. Other product families use different capacities.

Can the reservoir be partially filled?

The matrix should be evenly saturated without dry areas or excessive leaking. Do not intentionally underfill it to save medication or overfill it because more solution is available.

Can water be added to the drug electrode?

Only when the prescription and product instructions specifically call for a particular mixture. Some electrodes are designed for direct filling without separate water activation. Do not dilute or alter medication without professional authorization.

Which electrode receives the medication?

The active or drug-delivery electrode holds the medication. The return electrode completes the circuit and should not be filled with the medication unless a product’s instructions specifically describe a different system.

Which lead connects to dexamethasone?

Polarity must be determined from the exact medication form and prescription, not from the shortened word “dexamethasone.” When the prescribed ion is negative, the active drug electrode connects to the black negative lead. Consult our medication and polarity guide and verify the order.

How far should the return electrode be from the drug electrode?

Current Ionto4 instructions specify at least four inches on the same side of the body and over a major muscle. Other electrode systems may specify a different distance.

Can the return electrode be placed over a bone?

Avoid a prominent bone with little soft tissue. Ionto4 instructions recommend positioning the return electrode over a major muscle.

Is redness after treatment normal?

Uniform, temporary redness can occur beneath either electrode. Burning, blistering, severe pain, swelling, or a spreading rash requires further assessment.

What causes an electrode-reject warning?

Possible causes include a loose lead, a lifted electrode, poorly prepared skin, insufficient reservoir hydration, an unsuitable medication formulation, or another break in the circuit. The ActivaDose II stops current when it detects an electrode-reject condition.

Can an iontophoresis electrode be taped in place?

Do not tape, bind, or compress the electrode unless its current instructions expressly permit it. First determine why the adhesive is not maintaining contact. Incorrect size, skin preparation, placement, or medication leakage may be responsible.

Can the pads be removed temporarily and reapplied?

No. The active and return electrodes are designed for one continuous application. Once removed, they should be discarded.

Is the maximum dose always 80 mA-min?

No. Ionto4 permits up to 80 mA-min, but another electrode can have a different maximum. Follow the lowest applicable limit from the prescription, electrode IFU, and controller manual.

Can the current always be set to 4 mA?

No. Four milliamperes is the maximum for Ionto4 and ActivaDose II, not a required treatment setting. Patient comfort, anatomy, skin condition, and the professional order may require a lower current.

Final Pre-Treatment Checklist

Before pressing Start, confirm:

• The correct patient and treatment site
• The complete medication name and formulation
• The concentration and volume
• The medication polarity
• The prescribed mA-min dose
• The allowed current
• The correct electrode brand and size
• Intact, properly prepared skin
• Complete reservoir saturation
• No medication on the adhesive border
• Full active-electrode contact
• Suitable return-electrode placement
• Correct red and black lead connections
• No jewelry or metal touching either pad
• No external pressure over the electrodes
• The patient knows to report burning immediately
• The controller is displaying the intended dose and current

Key Takeaway

Safe wired iontophoresis depends on matching five elements:

1. The prescribed medication
2. The correct polarity
3. The correct reservoir and fill volume
4. The prescribed dose and tolerated current
5. Complete contact at both electrode sites

The most important improvement to the existing article is to avoid treating one electrode’s instructions as universal. Fill volume, included preparation supplies, polarity limits, maximum dose, and spacing requirements can vary by manufacturer and model.

For broader questions about iontophoresis, visit Iontophoresis Frequently Asked Questions. For condition-specific clinical discussions, browse our Iontophoresis Treatment Guide.